Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$433M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$419M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$332M |
| 5 |
RTX Corp
RTX
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AABA
Altaba Inc
AABA
|
+$267M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$181M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$134M |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
LVLT
Level 3 Communications Inc
LVLT
|
+$121M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.07% |
| 2 | Financials | 5.97% |
| 3 | Healthcare | 5.8% |
| 4 | Consumer Discretionary | 5.2% |
| 5 | Communication Services | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
4126
DELISTED
Calithera Biosciences, Inc
CALA
| $352K | ﹤0.01% |
2,100
+907
| +76% | +$232K |
|
|
DLPH
4127
CALL
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $352K | ﹤0.01% |
+6,699
| New | +$348K |
|
4128
PUT
Edgewell Personal Care
EPC
$1.31B
| $350K | ﹤0.01% |
5,900
+400
| +7% | +$25.2K |
|
4129
CALL
LiveRamp
RAMP
$2.3B
| $350K | ﹤0.01% |
+12,700
| New | +$333K |
|
4130
CALL
Sociedad Química y Minera de Chile
SQM
$20.6B
| $350K | ﹤0.01% |
5,900
+2,100
| +55% | +$120K |
|
|
REV
4131
DELISTED
Revlon, Inc.
REV
| $350K | ﹤0.01% |
16,047
-4,770
| -23% | -$106K |
|
4132
Comtech Telecommunications
CMTL
$51.8M
| $349K | ﹤0.01% |
15,779
+3,755
| +31% | +$80K |
|
4133
PUT
Synopsys
SNPS
$79.7B
| $349K | ﹤0.01% |
4,100
+3,600
| +720% | +$311K |
|
4134
Seaboard Corp
SEB
$4.06B
| $348K | ﹤0.01% |
79
+69
| +690% | +$299K |
|
4135
CALL
Canadian National Railway
CNI
$76.6B
| $347K | ﹤0.01% |
4,200
-24,000
| -85% | -$1.93M |
|
|
NTRI
4136
CALL
DELISTED
NutriSystem, Inc.
NTRI
| $347K | ﹤0.01% |
6,600
+6,100
| +1,220% | +$320K |
|
4137
AMERISAFE
AMSF
$540M
| $346K | ﹤0.01% |
5,619
+2,612
| +87% | +$164K |
|
4138
Murphy Oil
MUR
$4.78B
| $346K | ﹤0.01% |
11,166
-46,885
| -81% | -$1.31M |
|
|
SGMO
4139
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $346K | ﹤0.01% |
21,100
-13,000
| -38% | -$193K |
|
|
ATRI
4140
DELISTED
Atrion Corp
ATRI
| $346K | ﹤0.01% |
550
+217
| +65% | +$142K |
|
|
ORIG
4141
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
| $346K | ﹤0.01% |
+12,920
| New | +$328K |
|
4142
AZZ Inc
AZZ
$4.54B
| $345K | ﹤0.01% |
6,745
+4,688
| +228% | +$222K |
|
4143
Heritage Financial
HFWA
$1.21B
| $345K | ﹤0.01% |
11,193
+7,038
| +169% | +$217K |
|
|
ENV
4144
DELISTED
ENVESTNET, INC.
ENV
| $345K | ﹤0.01% |
6,925
+5,798
| +514% | +$300K |
|
4145
U-Haul Holding Co
UHAL
$14.6B
| $344K | ﹤0.01% |
9,120
+3,710
| +69% | +$139K |
|
|
CQH
4146
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $344K | ﹤0.01% |
12,434
-72,178
| -85% | -$1.89M |
|
4147
CALL
Cintas
CTAS
$81.3B
| $343K | ﹤0.01% |
8,800
-9,600
| -52% | -$365K |
|
4148
CALL
Community Health Systems
CYH
$423M
| $342K | ﹤0.01% |
80,200
+37,000
| +86% | +$186K |
|
4149
Modine Manufacturing
MOD
$10.4B
| $342K | ﹤0.01% |
16,966
+6,040
| +55% | +$130K |
|
4150
Abeona Therapeutics
ABEO
$413M
| $341K | ﹤0.01% |
862
-7,216
| -89% | -$2.98M |
|
Similar funds
Barclays's Q4 2017 Portfolio in Review
As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.
- Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
- Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
- Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
- Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
- Barclays opened 435 new positions and closed 356 in Q4 2017.
- Barclays's portfolio value rose 26% quarter-over-quarter to $122B.
Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.